Changes in transferrin saturation after treatment with the oral iron chelator deferiprone in patients with iron overload.

Eitemau Tebyg

• Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one or desferrioxamine.
  gan: al-Refaie, F N, et al.
  Cyhoeddwyd: (1994)
• The Oral Iron Chelator Deferiprone Protects against Iron Overload–Induced Retinal Degeneration
  gan: Hadziahmetovic, Majda, et al.
  Cyhoeddwyd: (2011)
• Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
  gan: Makis, Alexandros, et al.
  Cyhoeddwyd: (2013)
• Deferasirox, an oral chelator in the treatment of iron overload
  gan: I. Portioli
  Cyhoeddwyd: (2013-05-01)
• Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions
  gan: Neufeld, Ellis J.
  Cyhoeddwyd: (2006)